Prevención del tromboembolismo venoso durante el embarazo y el puerperio en Atención Primaria y Especializada

  1. J.L .Gallo-Vallejo 1
  2. M. Naveiro-Fuentes 1
  3. A. Puertas-Prieto 1
  4. F.J. Gallo-Vallejo 2
  1. 1 Hospital Universitario Virgen de las Nieves, Complejo Hospitalario Universitario de Granada
  2. 2 Distrito Sanitario de Atención Primaria Granada-Metropolitano, Armilla, Granada, España
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Ano de publicación: 2017

Número: 6

Páxinas: 450-456

Tipo: Artigo

DOI: 10.1016/J.SEMERG.2016.08.001 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Semergen: revista española de medicina de familia

Objetivos de desarrollo sostenible

Resumo

After noting that there are a number of risk factors for venous thromboembolism disease during pregnancy, it emphasizes primary prevention and treatment of this serious condition during pregnancy and the postpartum period are essential to reduce maternal morbidity and mortality. Low molecular-weight heparins are under the anticoagulant of choice in pregnancy. Your prescription may make both the primary care physician, as the hematologist and obstetrician. As for prescribing terms, an application protocol in both primary and specialized, multidisciplinary care, based on the existing literature on the subject is presented, which indicated that the hypercoagulable disorders associated with some of the risk factors, forced to do thromboprophylaxis with low molecular-weight heparins throughout pregnancy and the postpartum period presented.

Referencias bibliográficas

  • R. Guijarro, J. Montes, C. Sanromán Epidemiología hospitalaria de la enfermedad tromboembólica venosa en España Med Clin (Barc), 131 (Suppl 2) (2008), pp. S2-S9 Google Scholar
  • J.M. Calvo-Romero, E.M. Lima-Rodríguez Enfermedad tromboembólica venosa en la mujer Semergen, 33 (2007), pp. 228-230 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • D.J. O’Connor, L.A. Scher, N.J. Gargiulo 3rd., J. Jang, W.D. Suggs, E.C. Lipsitz Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period:A contemporary series Ann Vasc Surg., 25 (2011), pp. 9-14 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A.H. James, M.G. Jamison, L.R. Brancazio, E.R. Myers Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality Am J Obstet Gynecol, 194 (2006), pp. 1311-1315 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • G. Bourjeily, M. Paidas, H. Khalil, K. Rosene-Montella, M. Rodger Pulmonary embolism in pregnancy Lancet, 375 (2010), pp. 500-512 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • H.L. Brown, A.K. Hiett Deep vein thrombosis and pulmonary embolism in pregnancy: Diagnosis, complications, and management Clin Obstet Gynecol, 53 (2010), pp. 345-359 View Record in ScopusGoogle Scholar
  • A. Blanco-Molina, L.L. Rota, P. di Micco, B. Brenner, J. Trujillo-Santos, A. Ruiz-Gamietea, et al., RIETE Investigators Venous thromboembolism during pregnancy, postpartum or during contraceptive use Thromb Haemost, 103 (2010), pp. 306-311, 10.1160/TH09-08-0559 View PDFView Record in ScopusGoogle Scholar
  • I.A. Greer, C. Nelson-Piercy Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy Blood., 106 (2005), pp. 401-407 ArticleDownload PDFCrossRefView Record in ScopusGoogle Scholar
  • F. Ferrer, E. Oyarzún Trombosis venosa en el embarazo Rev Med Clin Condes, 25 (2014), pp. 1004-1018 View Record in ScopusGoogle Scholar
  • American College of Obstetricians and Gynecologists Women's Health Care Physicians ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy Obstet Gynecol, 122 (2013), pp. 706-717, 10.1097/01.AOG.0000433981.36184.4e View PDFGoogle Scholar
  • A.B. Cid, A. Sáez Pérdida gestacional recurrente y trombofilia Med Gen y Fam, 4 (2015), pp. 16-17 View Record in ScopusGoogle Scholar
  • S. Miyaki, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, R. Cervera, et al. International consensus statement on an update of the classification criteria for definitive antiphospholipd syndrome (APS) J Thromb Haemost, 4 (2006), pp. 295-306 Google Scholar
  • S.M. Bates, I.A. Greer, S. Middeldorp, D.L. Veenstra, A.M. Prabulos, P.O. Vandvik, American College of Chest Physicians VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest., 141 (2 Suppl) (2012), pp. e691S-e736S, 10.1378/chest.11-2300 ArticleDownload PDFGoogle Scholar
  • I.A. Greer Thrombosis in pregnancy: Updates in diagnosis and management Hematology Am Soc Hematol Educ Program., 2012 (2012), pp. 203-207, 10.1182/asheducation-2012.1.203 View PDFView Record in ScopusGoogle Scholar
  • A. Santamaría, J. Fontcuberta Anticoagulación y embarazo Med Clin (Barc)., 130 (2008), pp. 57-59 ArticleDownload PDFCrossRefView Record in ScopusGoogle Scholar
  • F. Buitrago, J. Alejandre, J.A. Morales Profilaxis del tromboembolismo e indicaciones de las heparinas de bajo peso molecular en atención primaria FMC., 18 (2011), pp. 281-291 Google Scholar
  • Valentine KA, Hull RD. Therapeutic use of heparin and low molecular weight heparin. 2012 [consultado 23 May 2016]. Disponible en: http://androsma.5gbfree.com/contents/mobipreview.htm?33/8/33930?source=related_link Google Scholar
  • A. James, Committee on Practice Bulletins–Obstetrics Practice bulletin no. 123: Thromboembolism in pregnancy Obstet Gynecol, 118 (2011), pp. 718-729 View Record in ScopusGoogle Scholar
  • Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No. 37a. London: RCOG [consultado 5 Feb 2016]; 2015. Disponible en:https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf Google Scholar
  • Enfermedad tromboembólica venosa en la gestación. Protocolos Asistenciales en Obstetricia. SEGO 2012 [consultado 9 Feb 2016]. Disponible en: http://www.elsevier.es/es-revista-progresosobstetricia-ginecologia-151-articulo-enfermedad-tromboembolica-venosagestacion-S0304501312003123 Google Scholar
  • P.G. Mirpuri-Mirpuri, M.M. Álvarez-Cordovés, A. Pérez-Monje Enfermedad tromboembólica venosa: a propósito de un caso Semergen, 39 (2013), pp. e15-e19 [consultado 4 Ago 2016]. Disponible en: http://dx.doi.org/10.1016/j.semerg.2012.07.001 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M.A. Rodger An update on thrombophilia and placenta mediated pregnancy complications: What should we tell our patients? Thromb Res, 131 (Suppl 1) (2013), pp. S25-S27, 10.1016/S0049-3848(13)70015-X ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A. Santamaría, B. Serra, M.F. López, M.A. Palomo, M. Casellas, E. Colomé, et al. Utilización de heparinas de bajo peso molecular para la profilaxis y el tratamiento de la enfermedad tromboembólica en pacientes embarazadas Prog Obstet Ginecol., 58 (2015), pp. 257-263 ArticleDownload PDFCrossRefView Record in ScopusGoogle Scholar
  • H.M. Knol, L. Schultinge, J.J. Erwich, K. Meijer Fondaparinux as an alternative anticoagulant therapy during pregnancy J Thromb Haemost, 8 (2010), pp. 1876-1879 View PDFCrossRefView Record in ScopusGoogle Scholar
Fonte de datos: Dialnet